Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6800586

O=C(NCCCn1nc2c(c1C(=O)O)CCc1cnccc1-2)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.44
ROCK2 O75116 4/20 0.40
MAPK10 P53779 1/20 0.39
MAPK14 Q16539 1/20 0.39
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTR1A P08908 1/20 0.37
HTR2A P28223 1/20 0.37
DRD3 P35462 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6791633 0.96 ALDH1A1 (0.44) NAMPTTSHRALDH1A1HTR1AHTR2A
Trifluoroacetic Acid SCHEMBL6795264 0.96 NPC1 (0.39) NAMPTROCK2TSHRSMN1; SMN2CYP1A2
Trifluoroacetic Acid SCHEMBL6800303 0.91 HTR1A (0.40) NAMPTHTR1AHTR2ADRD3SMN1; SMN2
Trifluoroacetic Acid SCHEMBL1655691 0.89 CDK2 (0.32) NAMPTROCK2TSHRHSP90AA1HSP90AB1
Trifluoroacetic Acid SCHEMBL6794262 0.89 SMN1; SMN2 (0.42) ROCK2TSHRALDH1A1HSP90AA1HSP90AB1
Trifluoroacetic Acid SCHEMBL6791904 0.89 ROCK2 (0.39) NAMPTROCK2TSHRALDH1A1HSP90AA1
SCHEMBL6800589 0.88 NAMPT (0.42) NAMPTROCK2MAPK10MAPK14TSHR
Trifluoroacetic Acid SCHEMBL6791540 0.88 CYP1A2 (0.34) NAMPTCYP1A2CYP3A4CYP2C9HPGD
Trifluoroacetic Acid SCHEMBL6794578 0.88 SMN1; SMN2 (0.45) ROCK2ALDH1A1SMN1; SMN2HPGD
Trifluoroacetic Acid SCHEMBL4263955 0.87 ALDH1A1 (0.38) ROCK2MAPK14ALDH1A1HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MKNK2, MAPKAPK2, MAP3K2 NAMPT 658/4885ROCK2 317/4885MAPK10 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.